simvastin - Trusted Medicine - Misspelled Drug Names

simvastin

Indications
Simvastin is used to treat Coronary heart disease, the drug is shown to patients: To reduce the risk of coronary mortality and the prevention of myocardial infarction; To reduce the risk of stroke and transient disorders of cerebral circulation; To reduce the likelihood of being subjected to the operation to restore coronary blood flow; With the aim of slowing progression coronary atherosclerosis.

Dosage
Typically, the starting dose is 10 mg every 1 per day evening. Simvastin designate initial dose of 20 mg 1 time / day evening. Correction dosing regimens, if necessary, should be the same as with hypercholesterolemia. Since simvastin output kidneys in a small number, there is no need to change the dose in patients with moderately expressed violations of kidney function. Patients with kidney function expressed violations (creatinine clearance less than 30 ml / min) should carefully evaluate the appropriateness of the appointment of simvastin in a dose greater than 10 mg / day. If this dose is considered necessary, should be appointed with caution.

Side effects
During the study, conducted an average of over 5.4 years, security and portability simvastin in groups of patients receiving simvastin (n = 2221) of 20-40 mg / day and placebo (n = 2223) were comparable. abdominal pain, constipation, flatulence (1% or more) further reported cases of nausea, diarrhea, dyspepsia, pancreatitis, vomiting, hepatitis, jaundice, perhaps expressed and sustained improvement in activity of transaminases (more than 3 times the upper limit of the rules) Variations in the rates of functional liver samples are usually poorly expressed and have a transitory nature. headache (0.5-0.9%), dizziness, muscle cramps, peripheral neuropathy. fever, hyperemia skin, shortness of breath. skin rash, itching, alopecia. Simvastin generally well tolerated; largely been slight and temporary side effects.

Contraindications
Liver disease (in the active phase); A persistent increase activity transaminases unclear etiology; Pregnancy; Lactation (breastfeeding); Increased sensitivity to the drug.